Anteris Technologies Global Corp.
IPORevolutionizing the heart valve replacement market | Anteris Technologies
Public · Eagan, United States · Founded 2006 · $344.1M raised
- Headquarters
- Eagan, Minnesota
- Employees
- 51–200
- Founded
- 2006
- Business Model
- B2B
- Website
- anteristech.com
- Total Funding
- $344.1M
- Last Round
- $320.0M Growth EquityJan 2025
- Rounds
- 2
- Type
- Public
About
Anteris Technologies is a global structural heart company founded in 2006 and headquartered in Eagan, Minnesota, focused on developing transcatheter heart valve solutions. Its flagship product, the DurAVR® Transcatheter Heart Valve, is a first-in-class biomimetic single-piece valve built from ADAPT® anti-calcification tissue designed to restore healthy aortic blood flow patterns. The company is publicly traded on both Nasdaq and the ASX, with operations across the United States, Europe, and Australia, and received a strategic $90 million investment from Medtronic.
Summary
Anteris Technologies Global Corp. is a Biotech company based in Eagan, United States, founded in 2006. It has raised $344.1M in total across 2 rounds, most recently a $320.0M Growth Equity round in Jan 2025. Investors include Medtronic, Janus Henderson Investors and Adage Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...